Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Oncotargets and Therapy|December 12, 2025
Prognostic Impact of Pre-Treatment CRP/Albumin Ratio in Patients with Advanced-Stage Epithelial Ovarian CancerFatih Atalah, Akgün Karakök, Aydın Acarbay, et al.
Journal of Clinical Medicine|November 27, 2025
KELIM PSA as a Prognostic Biomarker in Castration-Resistant Prostate Cancer Treated with ARPIFatih Atalah, Fatih Kuş, Aydın Acarbay, et al.
European Journal of Radiology|February 29, 2020
Relationship between KRAS mutation and diffusion weighted imaging in colorectal liver metastases; Preliminary studyMehmet Ali Gültekin, Hacı Mehmet Türk, Mehmet Beşiroğlu, et al.
Journal of Clinical Medicine|August 28, 2025
Malignancies After Renal Transplantation: Frequency, Etiology, and Prognosis-A Single Center ExperienceFatih Atalah, Aydın Acarbay, Akgün Karakök, et al.
Medicina (Kaunas, Lithuania)|July 30, 2025
Factors Affecting the Survival of Metastatic Breast Cancer Patients Treated with CDK 4/6 InhibitorsZehra Sucuoğlu İşleyen, Harun Muğlu, Zeynep Alaca Topçu, et al.
Turk Kardiyoloji Dernegi Arsivi : Turk Kardiyoloji Derneginin Yayin Organidir|November 17, 2025
Comparison of Ultrathin-Strut Sirolimus-Eluting Stents versus Drug-Coated Balloons in Small Coronary Vessels: Real-World DataBerhan Keskin, Aykun Hakgör, Atakan Dursun, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|May 19, 2020
Pazopanib for metastatic soft-tissue sarcoma: A multicenter retrospective studySinan Koca, Mehmet Beşiroğlu, Melike Özçelik, et al.
Current Problems in Cancer|August 18, 2020
Is lymph node dissection necessary for staging while undergoing nephrectomy in patients with renal cell carcinoma?Tarık Demir, Altay Aliyev, Mehmet Beşiroğlu, et al.
Pancreas|April 20, 2023
The Efficacy and Safety of Treatment Regimens Used in the First-Line Setting in Metastatic Pancreatic Cancer Patients: A Multicenter Real-Life StudyNadiye Akdeniz, Muhammet Ali Kaplan, Mevlüde İnanç, et al.
BMC Cancer|February 14, 2026
Evaluation of the efficacy and tolerability of bevacizumab-based treatments in recurrent primary brain tumors: a multicenter real-world Turkish Oncology Group (TOG) studyZehra Sucuoğlu İşleyen, Şaban Seçmeler, Abdullah Sakin, et al.
Pageof 2